| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunologic Deficiency Syndromes | 16 | 2024 | 242 | 3.370 |
Why?
|
| DiGeorge Syndrome | 8 | 2023 | 78 | 1.870 |
Why?
|
| Thymus Gland | 8 | 2013 | 298 | 1.650 |
Why?
|
| Genetic Testing | 5 | 2021 | 1675 | 1.490 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 5 | 2021 | 185 | 1.120 |
Why?
|
| Severe Combined Immunodeficiency | 5 | 2018 | 108 | 0.900 |
Why?
|
| Killer Cells, Natural | 8 | 2024 | 931 | 0.890 |
Why?
|
| RGS Proteins | 1 | 2021 | 60 | 0.770 |
Why?
|
| Body Height | 1 | 2021 | 236 | 0.720 |
Why?
|
| Parathyroid Glands | 2 | 2011 | 127 | 0.720 |
Why?
|
| Transplantation Tolerance | 2 | 2010 | 17 | 0.680 |
Why?
|
| Herpesvirus 4, Human | 3 | 2021 | 954 | 0.510 |
Why?
|
| Granulomatous Disease, Chronic | 3 | 2020 | 78 | 0.500 |
Why?
|
| Cytomegalovirus | 1 | 2018 | 482 | 0.490 |
Why?
|
| Mutation | 15 | 2022 | 15642 | 0.480 |
Why?
|
| Gain of Function Mutation | 4 | 2018 | 134 | 0.470 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2016 | 592 | 0.470 |
Why?
|
| Cytomegalovirus Infections | 1 | 2018 | 464 | 0.460 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2020 | 2341 | 0.450 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2018 | 488 | 0.440 |
Why?
|
| Sirolimus | 1 | 2018 | 834 | 0.440 |
Why?
|
| Haploinsufficiency | 3 | 2023 | 297 | 0.440 |
Why?
|
| Phenotype | 10 | 2021 | 6404 | 0.420 |
Why?
|
| Lymphatic System | 1 | 2012 | 65 | 0.410 |
Why?
|
| Genomics | 3 | 2022 | 2819 | 0.410 |
Why?
|
| Forkhead Transcription Factors | 2 | 2013 | 770 | 0.390 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2020 | 5716 | 0.380 |
Why?
|
| Transplantation, Homologous | 4 | 2011 | 2944 | 0.380 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 1708 | 0.380 |
Why?
|
| Agammaglobulinemia | 2 | 2021 | 45 | 0.380 |
Why?
|
| Infant | 19 | 2023 | 13818 | 0.350 |
Why?
|
| Genome, Human | 1 | 2018 | 1897 | 0.340 |
Why?
|
| Actins | 2 | 2024 | 615 | 0.330 |
Why?
|
| Common Variable Immunodeficiency | 2 | 2020 | 31 | 0.320 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2021 | 371 | 0.310 |
Why?
|
| B-Lymphocytes | 5 | 2021 | 1353 | 0.310 |
Why?
|
| Humans | 63 | 2024 | 270843 | 0.300 |
Why?
|
| STAT1 Transcription Factor | 2 | 2018 | 159 | 0.290 |
Why?
|
| Carrier Proteins | 3 | 2021 | 2055 | 0.290 |
Why?
|
| Genetic Association Studies | 6 | 2021 | 1091 | 0.280 |
Why?
|
| Alleles | 7 | 2020 | 2488 | 0.280 |
Why?
|
| Immunophenotyping | 5 | 2018 | 1701 | 0.260 |
Why?
|
| Autoimmune Diseases | 2 | 2019 | 418 | 0.250 |
Why?
|
| Membrane Proteins | 3 | 2020 | 2917 | 0.240 |
Why?
|
| Child, Preschool | 16 | 2023 | 16792 | 0.240 |
Why?
|
| Hypersensitivity | 2 | 2024 | 226 | 0.230 |
Why?
|
| Dermatitis | 1 | 2024 | 61 | 0.230 |
Why?
|
| Phospholipase C gamma | 1 | 2023 | 58 | 0.230 |
Why?
|
| Aging | 1 | 2012 | 1578 | 0.230 |
Why?
|
| CHARGE Syndrome | 1 | 2023 | 9 | 0.220 |
Why?
|
| Heterozygote | 4 | 2020 | 1043 | 0.220 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2023 | 61 | 0.220 |
Why?
|
| Pedigree | 7 | 2021 | 1937 | 0.210 |
Why?
|
| Child | 19 | 2023 | 30200 | 0.210 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2022 | 1168 | 0.210 |
Why?
|
| Arthritis | 2 | 2020 | 146 | 0.200 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2021 | 7 | 0.200 |
Why?
|
| Nonsense Mediated mRNA Decay | 2 | 2018 | 38 | 0.190 |
Why?
|
| Disease Management | 2 | 2018 | 1106 | 0.190 |
Why?
|
| Neutropenia | 2 | 2022 | 987 | 0.190 |
Why?
|
| Minichromosome Maintenance Proteins | 1 | 2020 | 10 | 0.190 |
Why?
|
| Colitis | 1 | 2024 | 338 | 0.190 |
Why?
|
| Homozygote | 2 | 2020 | 751 | 0.180 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 47 | 0.180 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2020 | 68 | 0.180 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 546 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2021 | 178 | 0.180 |
Why?
|
| X-Linked Combined Immunodeficiency Diseases | 1 | 2020 | 4 | 0.180 |
Why?
|
| Autoimmune Lymphoproliferative Syndrome | 1 | 2020 | 6 | 0.180 |
Why?
|
| Magnesium Deficiency | 1 | 2020 | 21 | 0.180 |
Why?
|
| GTP-Binding Proteins | 1 | 2021 | 325 | 0.180 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2023 | 362 | 0.180 |
Why?
|
| Mutation, Missense | 3 | 2020 | 1219 | 0.170 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2019 | 44 | 0.170 |
Why?
|
| Male | 30 | 2021 | 127630 | 0.170 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2019 | 15 | 0.170 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2019 | 76 | 0.170 |
Why?
|
| Infant, Newborn | 6 | 2022 | 8566 | 0.160 |
Why?
|
| DNA Copy Number Variations | 3 | 2021 | 1538 | 0.160 |
Why?
|
| Lymphopoiesis | 2 | 2021 | 17 | 0.160 |
Why?
|
| Sepsis | 2 | 2021 | 668 | 0.160 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 201 | 0.160 |
Why?
|
| Sequence Analysis, DNA | 3 | 2016 | 2506 | 0.160 |
Why?
|
| Lymphopenia | 1 | 2021 | 206 | 0.160 |
Why?
|
| Osteochondrodysplasias | 1 | 2019 | 73 | 0.160 |
Why?
|
| Female | 29 | 2021 | 147292 | 0.160 |
Why?
|
| Guanylate Cyclase | 1 | 2018 | 76 | 0.160 |
Why?
|
| Biliary Tract Diseases | 1 | 2018 | 63 | 0.160 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 355 | 0.160 |
Why?
|
| Immunologic Memory | 1 | 2020 | 376 | 0.160 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 79 | 0.160 |
Why?
|
| Nuclear Proteins | 3 | 2020 | 3385 | 0.150 |
Why?
|
| Immunological Synapses | 1 | 2018 | 31 | 0.150 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2021 | 463 | 0.150 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2018 | 107 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 480 | 0.150 |
Why?
|
| Immune System Diseases | 1 | 2018 | 66 | 0.150 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2018 | 112 | 0.150 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 232 | 0.150 |
Why?
|
| Alemtuzumab | 1 | 2018 | 208 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 627 | 0.150 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 161 | 0.150 |
Why?
|
| Viremia | 1 | 2018 | 183 | 0.140 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 258 | 0.140 |
Why?
|
| Adolescent | 12 | 2021 | 32336 | 0.140 |
Why?
|
| Models, Immunological | 2 | 2020 | 81 | 0.140 |
Why?
|
| Interferon Regulatory Factors | 1 | 2016 | 75 | 0.140 |
Why?
|
| DNA Damage | 3 | 2020 | 1989 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 441 | 0.140 |
Why?
|
| Cell Line | 5 | 2024 | 5132 | 0.140 |
Why?
|
| Data Interpretation, Statistical | 1 | 2018 | 496 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2014 | 172 | 0.140 |
Why?
|
| Coatomer Protein | 1 | 2016 | 33 | 0.130 |
Why?
|
| Immunoglobulins | 1 | 2016 | 268 | 0.130 |
Why?
|
| Chromosome Breakage | 1 | 2016 | 226 | 0.130 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2018 | 523 | 0.130 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2016 | 189 | 0.130 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2018 | 688 | 0.130 |
Why?
|
| Chromatin | 1 | 2021 | 972 | 0.130 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 4 | 2023 | 6776 | 0.130 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 676 | 0.130 |
Why?
|
| Cell Differentiation | 4 | 2021 | 4168 | 0.130 |
Why?
|
| Codon, Nonsense | 3 | 2021 | 164 | 0.130 |
Why?
|
| Trans-Activators | 1 | 2021 | 1624 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2018 | 1293 | 0.120 |
Why?
|
| Diagnosis, Differential | 3 | 2021 | 4862 | 0.120 |
Why?
|
| Neonatal Screening | 1 | 2015 | 181 | 0.120 |
Why?
|
| Computational Biology | 1 | 2020 | 1299 | 0.120 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1040 | 0.110 |
Why?
|
| Heart Defects, Congenital | 2 | 2023 | 1776 | 0.110 |
Why?
|
| Syndrome | 4 | 2021 | 1382 | 0.110 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2013 | 32 | 0.110 |
Why?
|
| Lung Diseases | 2 | 2016 | 741 | 0.110 |
Why?
|
| Parents | 2 | 2011 | 1047 | 0.110 |
Why?
|
| Genetic Variation | 2 | 2019 | 2112 | 0.110 |
Why?
|
| Liver Diseases | 1 | 2018 | 594 | 0.110 |
Why?
|
| Epilepsy | 1 | 2021 | 933 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2020 | 1059 | 0.110 |
Why?
|
| Virus Diseases | 1 | 2016 | 400 | 0.110 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 1698 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2019 | 5670 | 0.110 |
Why?
|
| Chromosome Deletion | 2 | 2023 | 1020 | 0.100 |
Why?
|
| Abnormalities, Multiple | 2 | 2016 | 1018 | 0.100 |
Why?
|
| Amino Acid Substitution | 3 | 2020 | 661 | 0.100 |
Why?
|
| Clone Cells | 1 | 2013 | 559 | 0.100 |
Why?
|
| NF-kappa B | 1 | 2019 | 1585 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 2560 | 0.100 |
Why?
|
| Autophagy | 1 | 2018 | 931 | 0.100 |
Why?
|
| Genes, MHC Class II | 1 | 2011 | 69 | 0.100 |
Why?
|
| Asthma | 1 | 2019 | 904 | 0.100 |
Why?
|
| Postoperative Period | 1 | 2013 | 674 | 0.100 |
Why?
|
| Cell Hypoxia | 1 | 2012 | 335 | 0.100 |
Why?
|
| Animals | 10 | 2023 | 61014 | 0.100 |
Why?
|
| Cytokines | 1 | 2020 | 2871 | 0.090 |
Why?
|
| Autoimmunity | 2 | 2024 | 275 | 0.090 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2010 | 92 | 0.090 |
Why?
|
| Lymphoma | 1 | 2019 | 1502 | 0.090 |
Why?
|
| Pseudolymphoma | 1 | 2010 | 22 | 0.090 |
Why?
|
| Transcription Factors | 2 | 2022 | 5362 | 0.090 |
Why?
|
| Cell Lineage | 1 | 2013 | 705 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2010 | 174 | 0.090 |
Why?
|
| Family | 3 | 2020 | 759 | 0.090 |
Why?
|
| Inflammation | 4 | 2024 | 2572 | 0.090 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2010 | 187 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 3363 | 0.090 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 2347 | 0.080 |
Why?
|
| Chromosomes | 2 | 2023 | 251 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2021 | 9487 | 0.080 |
Why?
|
| Immune Tolerance | 1 | 2011 | 408 | 0.080 |
Why?
|
| Histocompatibility Testing | 1 | 2010 | 465 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 717 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2017 | 1523 | 0.080 |
Why?
|
| BRCA2 Protein | 1 | 2010 | 375 | 0.080 |
Why?
|
| Models, Animal | 1 | 2011 | 691 | 0.080 |
Why?
|
| Adult | 10 | 2021 | 80709 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2021 | 7170 | 0.080 |
Why?
|
| Immunity, Innate | 1 | 2012 | 702 | 0.070 |
Why?
|
| Risk Factors | 3 | 2021 | 18267 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 2100 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2022 | 367 | 0.070 |
Why?
|
| Young Adult | 7 | 2021 | 22140 | 0.070 |
Why?
|
| Mice | 7 | 2023 | 35331 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2023 | 12151 | 0.070 |
Why?
|
| Graft Survival | 1 | 2010 | 1094 | 0.070 |
Why?
|
| DNA Replication | 2 | 2022 | 753 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2012 | 1158 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 4071 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2021 | 1513 | 0.060 |
Why?
|
| Bone Marrow | 1 | 2012 | 2381 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2021 | 6245 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2019 | 5804 | 0.060 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2023 | 19 | 0.060 |
Why?
|
| Janus Kinase 1 | 1 | 2024 | 125 | 0.060 |
Why?
|
| Biological Variation, Population | 1 | 2023 | 27 | 0.060 |
Why?
|
| Tissue Donors | 1 | 2007 | 793 | 0.060 |
Why?
|
| Herpesviridae Infections | 1 | 2023 | 178 | 0.050 |
Why?
|
| United States | 1 | 2019 | 16339 | 0.050 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2021 | 16 | 0.050 |
Why?
|
| Exome | 2 | 2018 | 1272 | 0.050 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2021 | 34 | 0.050 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2020 | 7 | 0.050 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2020 | 7 | 0.050 |
Why?
|
| Joints | 1 | 2020 | 45 | 0.050 |
Why?
|
| Consanguinity | 1 | 2021 | 114 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2019 | 1693 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 4911 | 0.050 |
Why?
|
| Prognosis | 1 | 2018 | 22249 | 0.050 |
Why?
|
| Uniparental Disomy | 1 | 2021 | 64 | 0.050 |
Why?
|
| Cytidine Deaminase | 1 | 2020 | 83 | 0.040 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 188 | 0.040 |
Why?
|
| CD4-CD8 Ratio | 1 | 2020 | 58 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 158 | 0.040 |
Why?
|
| India | 1 | 2020 | 306 | 0.040 |
Why?
|
| Genotype | 2 | 2019 | 4168 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2021 | 268 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2019 | 171 | 0.040 |
Why?
|
| Glycosylation | 1 | 2020 | 219 | 0.040 |
Why?
|
| T-Lymphocytes | 3 | 2022 | 3955 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2021 | 722 | 0.040 |
Why?
|
| Candidiasis, Chronic Mucocutaneous | 1 | 2018 | 5 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2024 | 748 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2020 | 278 | 0.040 |
Why?
|
| Immunity | 1 | 2021 | 359 | 0.040 |
Why?
|
| Busulfan | 1 | 2023 | 778 | 0.040 |
Why?
|
| Liver | 1 | 2009 | 2990 | 0.040 |
Why?
|
| Cation Transport Proteins | 1 | 2020 | 169 | 0.040 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2018 | 12 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2020 | 34238 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 834 | 0.040 |
Why?
|
| Cell Division | 1 | 2022 | 2556 | 0.040 |
Why?
|
| Ferritins | 1 | 2018 | 153 | 0.040 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 234 | 0.040 |
Why?
|
| Chimerism | 1 | 2018 | 64 | 0.040 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2018 | 36 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2018 | 249 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2021 | 573 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 113 | 0.040 |
Why?
|
| Pancytopenia | 1 | 2018 | 120 | 0.040 |
Why?
|
| Machine Learning | 1 | 2021 | 356 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 1083 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 577 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 1225 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2018 | 232 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2021 | 1163 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2018 | 237 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 471 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2021 | 367 | 0.040 |
Why?
|
| Multiple Organ Failure | 1 | 2018 | 182 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2018 | 261 | 0.040 |
Why?
|
| CD56 Antigen | 1 | 2016 | 84 | 0.040 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2018 | 199 | 0.030 |
Why?
|
| Biomarkers | 2 | 2020 | 5176 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 558 | 0.030 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2016 | 37 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 345 | 0.030 |
Why?
|
| Janus Kinases | 1 | 2017 | 177 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2016 | 91 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2016 | 83 | 0.030 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 430 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2021 | 1057 | 0.030 |
Why?
|
| Unrelated Donors | 1 | 2018 | 322 | 0.030 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2016 | 49 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2021 | 1476 | 0.030 |
Why?
|
| Zebrafish | 1 | 2019 | 470 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 684 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2020 | 7303 | 0.030 |
Why?
|
| Meiosis | 1 | 2016 | 172 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2023 | 3144 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 127 | 0.030 |
Why?
|
| Seizures | 1 | 2021 | 999 | 0.030 |
Why?
|
| Cause of Death | 1 | 2018 | 796 | 0.030 |
Why?
|
| Family Health | 1 | 2016 | 333 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 593 | 0.030 |
Why?
|
| Binding Sites | 1 | 2019 | 2210 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2016 | 255 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2018 | 756 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 1514 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2020 | 1410 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2021 | 1205 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2021 | 1119 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 1288 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2019 | 1769 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 1061 | 0.030 |
Why?
|
| Exons | 1 | 2018 | 1357 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2014 | 47 | 0.030 |
Why?
|
| Stem Cells | 1 | 2021 | 1244 | 0.030 |
Why?
|
| Complementarity Determining Regions | 1 | 2014 | 44 | 0.030 |
Why?
|
| Mitosis | 1 | 2016 | 623 | 0.030 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2014 | 102 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 1430 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2016 | 625 | 0.030 |
Why?
|
| Time Factors | 1 | 2007 | 13266 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 7738 | 0.030 |
Why?
|
| Neoplasms | 1 | 2019 | 15710 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2021 | 972 | 0.030 |
Why?
|
| Protein Binding | 1 | 2019 | 3483 | 0.030 |
Why?
|
| Nitriles | 1 | 2017 | 938 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2018 | 2317 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2019 | 1384 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2020 | 4887 | 0.030 |
Why?
|
| Base Sequence | 1 | 2018 | 4932 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 1134 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2016 | 712 | 0.020 |
Why?
|
| Texas | 1 | 2021 | 6460 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 599 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 9010 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 1149 | 0.020 |
Why?
|
| DNA Repair | 1 | 2016 | 1908 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2018 | 6224 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 13310 | 0.020 |
Why?
|
| ABO Blood-Group System | 1 | 2008 | 130 | 0.020 |
Why?
|
| Incidence | 1 | 2018 | 5904 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 7429 | 0.020 |
Why?
|
| Disease Progression | 1 | 2018 | 6891 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 2495 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2007 | 707 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2008 | 566 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2017 | 3609 | 0.020 |
Why?
|
| Skin | 1 | 2010 | 1284 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 14855 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2010 | 3074 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 15198 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2018 | 39512 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 72902 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2010 | 3033 | 0.010 |
Why?
|
| Biopsy | 1 | 2007 | 3490 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6269 | 0.010 |
Why?
|
| Middle Aged | 2 | 2016 | 89535 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2007 | 9324 | 0.010 |
Why?
|